Grant: Alliance Grants
University of Calgary
$68,000.00
Fabrication of Medical Cannula for advanced extracorporeal life support devices.
EF 2021-22
Résumé
Extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support (ECLS), is a technique of providing prolonged cardiac and respiratory support to persons whose heart and lungs are unable to sustain life. ECMO systems oxygenate the blood, taking over operation of the lungs and heart, allowing the organs to rest and recuperate, or while waiting for organ transplant. Current ECMO systems are bulky and complex for use in the field and are situated in hospitals ICUs (Intensive Care Units). Due to their proven lifesaving abilities, there is a strong move toward having ECMO units in ambulances. Canadian company Elsius Biomedical Corp. is developing a portable ECMO system to address this need. A crucial component of ECMO systems are the cannula, or tubes, that connect the system to the patient, enabling removal of the blood and reintroducing it back into the patient after reoxygenation. These cannulae have specific requirements to enable the ECMO process to work, such as pliability after insertion, kink resistance, long term biocompatibility, placement markers, dual lumen and flow control, to name a few, and are difficult to manufacture. Elsius is continuing a partnership with the Dalton Group to investigate, design, evaluate and develop a reliable and automated process for cannulae microfabrication which will allow Elsius to finalize their ECMO production cycle. This project will address technical challenges in the complex microfabrication process to create cannulae, by identifying and controlling key process variables such as cannulae geometry, coating temperature and dipping time, to ensure uniform layering. Once optimized, the process will be automated to create a repeatable and reliable manufacturing process. There are currently no cannulae manufacturers in Canada. As cannulae can be used in other medical situations, like cardiac surgery and neurosurgery, this engineering solution will result in many benefits to the Canadian Healthcare system.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
566795-2021
Name nom
Dalton, Colin
Department département
Electrical and Software Engineering
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
68000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:1
Partie
1
Nb partie
2
Application title
Fabrication of Medical Cannula for advanced extracorporeal life support devices.
Keyword
NSERC
Application summary
Extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support (ECLS), is a technique of providing prolonged cardiac and respiratory support to persons whose heart and lungs are unable to sustain life. ECMO systems oxygenate the blood, taking over operation of the lungs and heart, allowing the organs to rest and recuperate, or while waiting for organ transplant. Current ECMO systems are bulky and complex for use in the field and are situated in hospitals ICUs (Intensive Care Units). Due to their proven lifesaving abilities, there is a strong move toward having ECMO units in ambulances. Canadian company Elsius Biomedical Corp. is developing a portable ECMO system to address this need. A crucial component of ECMO systems are the cannula, or tubes, that connect the system to the patient, enabling removal of the blood and reintroducing it back into the patient after reoxygenation. These cannulae have specific requirements to enable the ECMO process to work, such as pliability after insertion, kink resistance, long term biocompatibility, placement markers, dual lumen and flow control, to name a few, and are difficult to manufacture. Elsius is continuing a partnership with the Dalton Group to investigate, design, evaluate and develop a reliable and automated process for cannulae microfabrication which will allow Elsius to finalize their ECMO production cycle. This project will address technical challenges in the complex microfabrication process to create cannulae, by identifying and controlling key process variables such as cannulae geometry, coating temperature and dipping time, to ensure uniform layering. Once optimized, the process will be automated to create a repeatable and reliable manufacturing process. There are currently no cannulae manufacturers in Canada. As cannulae can be used in other medical situations, like cardiac surgery and neurosurgery, this engineering solution will result in many benefits to the Canadian Healthcare system.